| A | Arthritis/arthralgia |
| AML | Acute myeloid leukemia |
| ANA | Antinuclear antibody |
| AOSD | Adult-onset Still’s disease |
| ARDS | Acute respiratory distress syndrome |
| C | Cytolysis |
| CBC | Complete blood count |
| CC | Corticosteroids |
| CMML | Chronic myelomonocytic leukemia |
| CPSS | CMML-specific prognostic scoring system |
| CR | Complete remission |
| CRP | C-reactive protein |
| DIC | Disseminated intravascular coagulation |
| F | Female |
| F | Fever |
| Fr | High ferritin |
| G | Low glycosylated ferritin |
| IL | Interleukin |
| ILD | interstitial lung disease |
| L | Lymph nodes and splenomegaly |
| M | Male |
| M/F | Male-to-female ratio |
| MAS | Macrophage activation syndrome |
| MDS | Myelodysplastic syndrome |
| MDS MLD | MDS with multilineage dysplasia |
| MDS SLD | MDS with single lineage dysplasia |
| MDS-EB1 | MDS with excess of blasts <5% |
| MDS-EB2 | MDS with excess of blasts >5% |
| MDS-RS | MDS with ring sideroblasts |
| MM | Myelodysplastic malignancy |
| MTX | Methotrexate |
| PNN | Polymorphonuclear neutrophils >80% |
| PET scan | Positron emission tomography scan |
| PR | Partial remission |
| RF | Rheumatoid factor |
| RHS | Reactive hemophagocytic syndrome |
| R-IPPS | Revised International Prognostic Scoring System |
| SAID | Systemic autoinflammatory disorder |
| S | Skin rash |
| T | Sore throat |
| TNF | Tumor necrosis factor |
| UBA1 | Ubiquitin-like modifier activating enzyme 1 |
| USAID | Undifferentiated systemic autoinflammatory disorder |
| VEXAS | Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome |
| W | Leukocytosis |
| Yrs | Years |